IV CR845

Shares of Cara Therapeutics Inc (NASDAQ: CARA) were trading higher by more than 9 percent early Wednesday morning after the company confirmed the U.S. Food and Drug Administration (FDA) removed a hold on a clinical trial. Cara Therapeutics said it received notice from the FDA that the agency...